nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accelerated hyperfractionated thoracic radiation therapy (AHTRT) plus concomitant VP16-CDDP chemotherapy for unresectable stage III non-small cell lung cancer (NSCLC)
|
|
|
1994 |
10 |
S1 |
p. S336- 1 p. |
artikel |
2 |
A comparison of methods for Phase II cancer clinical trials: advantages of the triangular test, a group sequential method
|
Bellissant, Eric |
|
1994 |
10 |
S1 |
p. S105-S115 11 p. |
artikel |
3 |
Alternating radiotherapy and chemotherapy in limited small cell lung cancer: the IGR protocols
|
Arriagada, R. |
|
1994 |
10 |
S1 |
p. S289-S298 10 p. |
artikel |
4 |
A phase III randomized study of concurrent radical accelerated radiotherapy (RT) and carboplatin in inoperable non-small cell lung cancer (NSCLC)
|
|
|
1994 |
10 |
S1 |
p. S335- 1 p. |
artikel |
5 |
A phase II study of vindesine and cisplatin (VP) used concurrently with thoracic radiotherapy (TRT) for locally advanced non-small cell lung cancer (NSCLC)
|
|
|
1994 |
10 |
S1 |
p. S336- 1 p. |
artikel |
6 |
Biological basis of combined therapy
|
Souhami, R.L. |
|
1994 |
10 |
S1 |
p. S3-S5 3 p. |
artikel |
7 |
Biology of lung cancer
|
Stahel, Rolf A. |
|
1994 |
10 |
S1 |
p. S59-S65 7 p. |
artikel |
8 |
Challenges of preoperative chemotherapy in non-small cell lung cancer
|
Johnson, David H. |
|
1994 |
10 |
S1 |
p. S195-S203 9 p. |
artikel |
9 |
Characterization of camptothecin analog (CPT-11) resistant human lung cancer cells and its resistance mechanism
|
|
|
1994 |
10 |
S1 |
p. S332-S333 2 p. |
artikel |
10 |
Chemotherapy dose intensity in small cell lung cancer
|
Souhami, R.L. |
|
1994 |
10 |
S1 |
p. S175-S185 11 p. |
artikel |
11 |
Chemotherapy preceding surgery and radiotherapy in non-small cell lung cancer (NSCLC) patients with biopsy-proven N2 disease: a phase II EORTC study
|
|
|
1994 |
10 |
S1 |
p. S334- 1 p. |
artikel |
12 |
Combined modality therapy in small cell lung cancer
|
Bunn, P. |
|
1994 |
10 |
S1 |
p. S25-S28 4 p. |
artikel |
13 |
Combined modality treatment for locally advanced non-small cell lung cancer — which control arm?
|
Johnson, David H. |
|
1994 |
10 |
S1 |
p. S231-S238 8 p. |
artikel |
14 |
Combined radiation and chemotherapy for unresectable non-small cell lung carcinoma
|
Bleehen, N.M. |
|
1994 |
10 |
S1 |
p. S19-S23 5 p. |
artikel |
15 |
Comparison of treatment results between interdigitating and simultaneous chemotherapy and radiotherapy for limited small cell lung cancer
|
|
|
1994 |
10 |
S1 |
p. S339- 1 p. |
artikel |
16 |
Complications associated with the treatment of small cell lung cancer
|
Feld, Ronald |
|
1994 |
10 |
S1 |
p. S307-S317 11 p. |
artikel |
17 |
Concomitant chemoradiotherapy for non-small cell lung cancer
|
Vokes, Everett E. |
|
1994 |
10 |
S1 |
p. S253-S261 9 p. |
artikel |
18 |
Concurrent approaches to combined chemotherapy and chest radiotherapy for the treatment of patients with limited stage small cell lung cancer
|
Johnson, Bruce E. |
|
1994 |
10 |
S1 |
p. S281-S287 7 p. |
artikel |
19 |
Concurrent carboplatin (CBDCA) and radiotherapy (RT) for unresectable stage III (Mo) non-small cell lung cancer (NSCLC)
|
|
|
1994 |
10 |
S1 |
p. S335-S336 2 p. |
artikel |
20 |
Concurrent platinum (CDDP)-etoposide (VP-16) chemotherapy plus thoracic radiotherapy (TRT) for limited stage small cell lung cancer (SCLC)
|
|
|
1994 |
10 |
S1 |
p. S337- 1 p. |
artikel |
21 |
Considerations on radiotherapy dose intensity for limited small cell lung cancer
|
Turrisi, Andrew T. |
|
1994 |
10 |
S1 |
p. S167-S173 7 p. |
artikel |
22 |
Delayed chest irradiation for patients with limited stage (LS) small cell lung cancer (SCLC)
|
|
|
1994 |
10 |
S1 |
p. S338-S339 2 p. |
artikel |
23 |
Does adjuvant chemotherapy decrease distant metastasis formation in patients with non-small cell lung cancer?
|
Green, Mark R. |
|
1994 |
10 |
S1 |
p. S187-S194 8 p. |
artikel |
24 |
Dose intensity in lung cancer treatment
|
Cox, J. |
|
1994 |
10 |
S1 |
p. S11-S13 3 p. |
artikel |
25 |
Dose intensity of radiation therapy in non-small cell carcinoma of the lung: a review of RTOG data and strategies
|
Cox, James D. |
|
1994 |
10 |
S1 |
p. S161-S166 6 p. |
artikel |
26 |
Early stopping rules and long-term follow-up in Phase III trials
|
Pignon, Jean-Pierre |
|
1994 |
10 |
S1 |
p. S151-S159 9 p. |
artikel |
27 |
Effects of All-Trans Retinoic (TRA) on small cell lung cancer (SCLC)
|
|
|
1994 |
10 |
S1 |
p. S331-S332 2 p. |
artikel |
28 |
Factors confounding evaluation of treatment effect in lung cancer
|
Østerlind, Kell |
|
1994 |
10 |
S1 |
p. S97-S103 7 p. |
artikel |
29 |
Factors influencing use of alternating chemotherapy and radiation schedules in small cell lung cancer
|
Gregor, Anna |
|
1994 |
10 |
S1 |
p. S299-S305 7 p. |
artikel |
30 |
Fractionation and dose in thoracic radiotherapy
|
Saunders, M.I. |
|
1994 |
10 |
S1 |
p. S245-S252 8 p. |
artikel |
31 |
Fundamental bases of combined therapy in lung cancer: cell resistance to chemotherapy and radiotherapy
|
Duchesne, Gillian M. |
|
1994 |
10 |
S1 |
p. S67-S72 6 p. |
artikel |
32 |
Infusion cisplatin based chemotherapy plus accelerated hyperfractionated thoracic radiation therapy for limited small cell carcinoma of the lung
|
|
|
1994 |
10 |
S1 |
p. S339-S340 2 p. |
artikel |
33 |
Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistance
|
Mulshine, James L. |
|
1994 |
10 |
S1 |
p. S73-S81 9 p. |
artikel |
34 |
Introduction
|
|
|
1994 |
10 |
S1 |
p. S1- 1 p. |
artikel |
35 |
Investigations with PET-scan, Octreoscan and in vitro-assay of sensitivity to cytotoxic drugs in SCLC. A preliminary report
|
|
|
1994 |
10 |
S1 |
p. S331- 1 p. |
artikel |
36 |
Is preoperative or postoperative radiation therapy indicated in non-small cell cancer of the lung?
|
Payne, David G. |
|
1994 |
10 |
S1 |
p. S205-S212 8 p. |
artikel |
37 |
Meta-analyses of randomized clinical trials: how to improve their quality?
|
Pignon, Jean-Pierre |
|
1994 |
10 |
S1 |
p. S135-S141 7 p. |
artikel |
38 |
Modelling the consequences of delay in the timing of thoracic irradiation (TI) in the combined modality treatment of limited stage small cell lung cancer (LSCLC)
|
|
|
1994 |
10 |
S1 |
p. S337-S338 2 p. |
artikel |
39 |
Modelling the process of drug resistance
|
Goldie, James H. |
|
1994 |
10 |
S1 |
p. S91-S96 6 p. |
artikel |
40 |
New perspectives in combined radiotherapy and chemotherapy treatment
|
Tannock, Ian F. |
|
1994 |
10 |
S1 |
p. S29-S51 23 p. |
artikel |
41 |
Normal lung biology
|
Mattson, Karin |
|
1994 |
10 |
S1 |
p. S53-S58 6 p. |
artikel |
42 |
Phase III studies in the therapy of small cell lung cancer (SCLC) : a North Central Cancer Treatment Group (NCCTG) trial
|
|
|
1994 |
10 |
S1 |
p. S338- 1 p. |
artikel |
43 |
Pitfalls and biases in the reporting and interpretation of the results of clinical trials
|
Parmar, Mahesh K.B. |
|
1994 |
10 |
S1 |
p. S143-S150 8 p. |
artikel |
44 |
Predictive testing of radiosensitivity in non-small cell carcinoma of the lung
|
Saunders, M.I. |
|
1994 |
10 |
S1 |
p. S83-S90 8 p. |
artikel |
45 |
Pre-operative and post-operative treatments in Stage III NSCLC
|
Green, M. |
|
1994 |
10 |
S1 |
p. S15-S17 3 p. |
artikel |
46 |
Radiation sensitivities in various anticancer drug resistant human lung cancer cell lines and mechanism of radioresistance in cis-Diamminedichloroplatinum (II) resistant lung cancer cell line
|
|
|
1994 |
10 |
S1 |
p. S333- 1 p. |
artikel |
47 |
Radiosensitization by cytotoxic drugs. The EORTC experience by the Radiotherapy and Lung Cancer Cooperative Groups
|
Schaake-Koning, C. |
|
1994 |
10 |
S1 |
p. S263-S270 8 p. |
artikel |
48 |
Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma
|
Le Chevalier, Thierry |
|
1994 |
10 |
S1 |
p. S239-S244 6 p. |
artikel |
49 |
Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer
|
|
|
1994 |
10 |
S1 |
p. S337- 1 p. |
artikel |
50 |
Should current management of small cell lung cancer include prophylactic cranial irradiation?
|
Kristjansen, Paul E.G. |
|
1994 |
10 |
S1 |
p. S319-S329 11 p. |
artikel |
51 |
Staging of lung cancer
|
|
|
1994 |
10 |
S1 |
p. S333-S334 2 p. |
artikel |
52 |
Surgical considerations after preoperative treatment
|
Ginsberg, Robert J. |
|
1994 |
10 |
S1 |
p. S213-S217 5 p. |
artikel |
53 |
The response of non-small cell lung cancer to palliative radiotherapy is enhanced by the concurrent administration of 5-fluorouracil (5FU)
|
|
|
1994 |
10 |
S1 |
p. S334-S335 2 p. |
artikel |
54 |
Toxicity of combined radiation and chemotherapy in non-small cell lung cancer
|
Van Houtte, P. |
|
1994 |
10 |
S1 |
p. S271-S280 10 p. |
artikel |
55 |
Toxicity of thoracic radiotherapy on pulmonary function in lung cancer
|
Choi, Noah C. |
|
1994 |
10 |
S1 |
p. S219-S230 12 p. |
artikel |
56 |
Treatment evaluation
|
Hansen, H. |
|
1994 |
10 |
S1 |
p. S7-S9 3 p. |
artikel |
57 |
Treatment evaluation of combined modality therapy: ‘What can we obtain today from Phase II trials?’
|
Thatcher, N. |
|
1994 |
10 |
S1 |
p. S117-S133 17 p. |
artikel |